FDA Clears COVID-19 Boosters For 5-11 Age Group
The U.S. Food and Drug Administration said Tuesday that it was approving a booster dose of the Pfizer-BioNTech vaccine for children between 5 and 11 years old, a move that comes...To view the full article, register now.
Already a subscriber? Click here to view full article